Transpek Industry · Material risks, their source context, and severity in the latest available quarter.
ConCallIQ research layer
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Risk intelligence
Renewal discussions expected Q4 CY26-Q1 CY27. Management acknowledged this would be a significant blow in terms of volume and margins if not renewed, though no specific contingency revenue replacement was quantified.
Rs 300 crore investment (45-50% of market cap/net worth) declining in value; dividend yield of Rs 5-7 crore annually is inadequate. Shareholder agreement with right of first refusal for Sylox limits monetization options. Sylox itself investing heavily in new facilities (Orissa) and unlikely to buy out.
8-9 new domestic competitors have entered acid chloride market over 6-7 years. While Transpek has sustained market share, formula-based Dupont pricing means raw material volatility flows through to revenue, and competitive pressure affects negotiated pricing in Indian/Korean/Chinese markets.
One product under development for battery electrolyte application had to be suspended as customer changed end-application technology requirements. Requires complete re-trial process with modified specifications.
